4-Chlorobenzo [b] thiophene CAS 66490-33-3 Tsarkake> 98.0% (GC) Brexpiprazole Matsakaici Factory Featured Image

4-Chlorobenzo [b] thiophene CAS 66490-33-3 Tsafta > 98.0% (GC) Brexpiprazole Intermediate Factory

Takaitaccen Bayani:

Sunan Sinadari: 4-Chlorobenzo[b]thiophene

Saukewa: 66490-33-3

Tsafta:> 98.0% (GC)

Bayyanar: Ruwa mara launi

Matsakaicin Brexpiprazole (CAS: 913611-97-9)

Kyakkyawan inganci, Samar da Kasuwanci

E-Mail: alvin@ruifuchem.com

Aika mana imel

Cikakken Bayani

Samfura masu dangantaka

Tags samfurin

Bayani:

Ruifu Chemical Supply Brexpiprazole Intermediates
Brexpiprazole CAS 913611-97-9
7-Hydroxyquinolinone CAS 70500-72-0
4-Bromobenzo [b] thiophene CAS 5118-13-8
1- (1-Benzothiophen-4-yl) Piperazine Hydrochloride CAS 913614-18-3
7- (4-Chlorobutoxy) quinolin-2(1H) -daya CAS 913613-82-8
4-Chlorobenzo [b] thiophene CAS 66490-33-3

Abubuwan Sinadarai:

Sunan Sinadari	4-Chlorobenzo [b] thiophene
Makamantu	4-Chloro-Benzo[b]thiophene;4-Chloro-1-Benzothiophene;4-Chlorobenzothiophene
Lambar CAS	66490-33-3
Lambar CAT	RF-PI1983
Matsayin Hannun jari	A cikin Hannun jari, Ma'aunin samarwa Har zuwa Ton
Tsarin kwayoyin halitta	Saukewa: C8H5ClS
Nauyin Kwayoyin Halitta	168.64
Alamar	Ruifu Chemical

Ƙayyadaddun bayanai:

Abu	Ƙayyadaddun bayanai
Bayyanar	Ruwa mara launi
Tsarkake / Hanyar Bincike	> 98.0% (GC)
Jimlar ƙazanta	<2.00%
Infrared Spectrum	Yayi daidai da Tsarin
NMR	Yayi daidai da Tsarin
Matsayin Gwaji	Matsayin Kasuwanci
Amfani	Matsakaicin Brexpiprazole (CAS: 913611-97-9)

Kunshin & Ajiya:

Kunshin: Fluorinated Bottle, 25kg/Drum, ko bisa ga abokin ciniki ta bukata

Yanayin Ajiya:Ajiye a cikin kwantena da aka rufe a wuri mai sanyi da bushe;Kare daga haske da danshi

Amfani:

FAQ:

Aikace-aikace:

4-Chlorobenzo [b] thiophene (CAS: 66490-33-3) Matsakaici ne na Brexpiprazole (CAS: 913611-97-9).Brexpiprazole wani sabon magani ne na antipsychotic wanda ke aiki azaman mai sarrafa ayyukan serotonin ® dopamine kuma ya nuna inganci azaman jiyya na haɗin gwiwa a cikin marasa lafiya tare da babban rashin damuwa (MDD).Magungunan yana nuna bayanin martaba na musamman na pharmacological, yana aiki azaman agonist na serotonin 5-HT1A da masu karɓa na dopamine D2 kuma a matsayin cikakken antagonist na 5-HT2A da noradrenaline α1B / 2C masu karɓa, tare da alaƙar haɗin kai na subnanomolar iri ɗaya.Magungunan, wanda Otsuka da Lundbeck suka kirkira, an amince da shi a cikin 2015 ta FDA don maganin schizophrenia da kuma a matsayin ƙarin magani don damuwa.An yi la'akari da Brexpiprazole a matsayin magajin Otsuka's antipsychotic miyagun ƙwayoyi aripiprazole (sunan ciniki Abilify) wanda ikon mallaka ya ƙare a watan Agusta 2014.